Diagnosing Rett syndrome involves careful observation of a child’s development and genetic testing to confirm the presence of specific mutations. This rare neurological disorder primarily affects girls and typically becomes noticeable when developmental milestones are missed or previously learned skills are lost.

Introduction: When to Seek Diagnostic Evaluation

Parents often notice something is different when their child stops developing as expected or begins losing skills they had already learned. Rett syndrome typically reveals itself between 6 and 18 months of age, though the earliest signs can be subtle and easily overlooked. If your child appears to develop normally during the first six months of life but then shows signs of developmental stagnation or regression, it’s time to consult with a healthcare professional.^[1]

The diagnosis should be considered when a child’s head growth begins to slow down, when there are problems with movement and coordination, or when language skills fail to develop or are lost. Many parents first become concerned when they notice their child has stopped making eye contact, shows reduced interest in toys, or experiences feeding difficulties. These early warning signs warrant a thorough evaluation by a specialist familiar with neurodevelopmental disorders.^[2]

Girls are almost exclusively affected by Rett syndrome, though extremely rare cases in boys have been documented. Boys with similar mutations typically experience more severe outcomes. Because the condition is rare—affecting approximately 1 in 10,000 girls—many healthcare providers may not immediately recognize the symptoms, making parent advocacy and awareness particularly important.^[3]

Classic Diagnostic Methods

Diagnosing Rett syndrome begins with careful clinical observation rather than a single definitive test. Healthcare providers conduct a thorough physical examination and gather detailed information about the child’s developmental history and medical background. They pay special attention to when symptoms first appeared and how they have progressed over time. This developmental timeline is crucial because Rett syndrome follows a characteristic pattern of normal early development followed by regression.^[4]

The diagnosis of classic or typical Rett syndrome requires the presence of specific core symptoms. These include partial or complete loss of purposeful hand skills, partial or complete loss of spoken language, problems with walking such as an unsteady gait or inability to walk, and repetitive hand movements. These hand movements are particularly distinctive—they often appear as wringing, washing, clapping, or tapping motions that the child cannot easily control. Doctors look for these characteristic behaviors as key indicators of the condition.^[5]

Healthcare providers must rule out other conditions that might cause similar symptoms before confirming a Rett syndrome diagnosis. This process, called differential diagnosis (distinguishing one condition from others with similar features), is essential because several other disorders can mimic Rett syndrome. Conditions that need to be excluded include autism spectrum disorder, cerebral palsy, other genetic disorders, hearing or vision problems, and metabolic disorders such as phenylketonuria (a genetic condition affecting how the body processes protein).^[10]

To exclude these other conditions, doctors may order various tests. Blood tests can identify metabolic disorders and other genetic conditions. Urine tests may be used to detect certain abnormalities in body chemistry. Imaging tests such as magnetic resonance imaging (MRI) (a scan that uses magnets and radio waves to create detailed pictures of the brain) or computerized tomography (CT) scans (X-ray images that show cross-sections of the body) can reveal structural problems in the brain, though these imaging studies typically appear normal in Rett syndrome.^[10]

Additional diagnostic procedures may include hearing tests to ensure that language problems aren’t caused by hearing loss, and eye and vision exams to rule out visual impairment. Brain activity tests called electroencephalograms or EEGs (tests that record electrical activity in the brain) may be performed, especially if the child experiences seizures, which occur in many individuals with Rett syndrome. These tests help paint a complete picture and ensure nothing else is causing the symptoms.^[10]

The diagnostic process often involves tracking the child through different stages of the condition. Rett syndrome is described in four stages, and symptoms may overlap between stages. Stage 1, called early onset, typically begins between 6 and 18 months and is characterized by subtle signs like low muscle tone, feeding difficulties, and delayed speech development. Stage 2, the rapid progressive or regression stage, usually occurs between ages 1 and 4, when the child loses previously acquired abilities and develops the characteristic hand movements.^[5]

Stage 3, known as the plateau stage, can begin as early as age 2 or as late as age 10 and may last for many years. During this phase, some symptoms from stage 2 may actually improve, with better social interaction and communication. Stage 4, characterized by deterioration in movement, can last for years or decades. Understanding which stage a child is in helps doctors provide appropriate care and set realistic expectations for families.^[5]

Genetic Testing

Once clinical observation suggests Rett syndrome, genetic testing is performed to confirm the diagnosis. A simple blood test is used to look for mutations in the MECP2 gene (a gene that contains instructions for making a protein needed for brain development). This gene is located on the X chromosome, which is one of the two sex chromosomes. Almost all cases of Rett syndrome—approximately 90 percent—are caused by mutations in this specific gene.^[7]

The MECP2 gene produces a protein called methyl CpG binding protein 2, or MeCP2, which acts like a switch that turns other genes on and off. This protein is particularly important for the development and function of nerve cells in the brain. When the MECP2 gene doesn’t work properly due to a mutation, the brain doesn’t develop or function as it should, leading to the symptoms of Rett syndrome.^[3]

It’s important to understand that genetic testing alone is not sufficient for diagnosis. Most people with a clinical diagnosis of Rett syndrome—between 80 and 97 percent—have a detectable change in the MECP2 gene. However, having an MECP2 mutation doesn’t automatically mean a person has Rett syndrome. Some individuals carry mutations in this gene but don’t develop the full syndrome. Therefore, doctors rely on both clinical symptoms and genetic testing together to make a diagnosis.^[4]

In most cases, Rett syndrome is not inherited from parents. Over 99 percent of cases occur as new, random mutations, meaning they happen spontaneously rather than being passed down through families. This is why there is usually no family history of the condition. The mutation typically occurs randomly in the egg or sperm cell before conception, or very early in fetal development.^[5]

Some children may have what’s called atypical or variant Rett syndrome. These individuals show some but not all of the classic features of the condition. Genetic testing may reveal mutations in other genes, such as the CDKL5 gene (another gene involved in brain development), though mutations in MECP2 remain the most common cause. Understanding the specific genetic mutation can help predict the course of the disease and guide treatment decisions.^[7]

Diagnostics for Clinical Trial Qualification

When individuals with Rett syndrome are being considered for participation in clinical trials, they typically undergo additional testing beyond the standard diagnostic procedures. Clinical trials are research studies that test new treatments, and they have specific requirements that participants must meet. These requirements help ensure the safety of participants and the reliability of the study results.^[13]

Genetic confirmation is usually mandatory for clinical trial enrollment. Researchers need documented proof of an MECP2 mutation through genetic testing performed by an accredited laboratory. This confirmation ensures that all study participants have the same underlying cause for their condition, which makes it easier to measure whether a treatment is working. The specific type and location of the mutation within the gene may also affect eligibility for certain trials, as some treatments target particular types of genetic changes.^[4]

Clinical trials typically require comprehensive baseline assessments to establish each participant’s starting point before any experimental treatment begins. These assessments often include detailed evaluations of motor skills, communication abilities, behavioral patterns, and overall functioning. Standardized rating scales may be used to measure the severity of symptoms, allowing researchers to track changes over time. Parents or caregivers are frequently asked to complete questionnaires about their child’s daily activities and abilities.^[13]

Physical examinations and laboratory tests are standard requirements for trial participation. Blood tests may be performed to check liver and kidney function, ensuring that the child’s organs are healthy enough to process experimental medications. Heart function is carefully evaluated because individuals with Rett syndrome can have heart rhythm abnormalities. An electrocardiogram (ECG) may be required to measure the heart’s electrical activity and check for problems with heart rhythm, particularly prolonged QT syndrome (a condition affecting the heart’s electrical recharging system that can cause dangerous irregular heartbeats).^[4]

Age and developmental stage often determine trial eligibility. Many clinical trials focus on specific age groups, such as young children or adolescents, because Rett syndrome affects people differently at various life stages. Researchers may require participants to be within certain stages of the disease progression or to have specific symptoms that the experimental treatment is designed to address. Some trials may exclude individuals who have certain complications or who are taking specific medications that could interfere with the study.^[13]

Imaging studies such as brain MRI scans may be required for some trials to establish baseline brain structure and rule out other neurological conditions. While brain imaging typically appears relatively normal in Rett syndrome—showing perhaps slightly smaller brain size overall—these scans provide important baseline data and help researchers understand how the brain may change in response to treatment.^[10]

Some trials measure outcomes using objective technologies such as wearable devices that monitor movement, breathing patterns, and other physiological measures throughout the day and night. These devices provide continuous data that can reveal changes in symptoms that might not be apparent during brief clinical visits. Such monitoring technologies represent an advancement in how researchers can measure treatment effects in Rett syndrome.^[15]

Natural history studies, which track the progression of Rett syndrome over time without testing specific treatments, also require diagnostic procedures. These studies collect comprehensive data about how the condition develops and changes, creating valuable information that helps design better clinical trials. Participation in natural history studies often involves regular assessments of development, behavior, health complications, and quality of life measures. This information benefits not just individual families but the entire Rett syndrome community by advancing scientific understanding of the condition.^[11]